Serum FGF21 levels in adult m.3243A>G carriers Clinical implications

被引:34
作者
Koene, Saskia [1 ]
de Laat, Paul [1 ]
van Tienoven, Doorlene H. [2 ]
Vriens, Dennis [3 ]
Brandt, Andre M. [2 ]
Sweep, Fred C. G. J. [2 ]
Rodenburg, Richard J. T. [1 ]
Donders, A. Rogier T. [4 ]
Janssen, Mirian C. H. [1 ,5 ]
Smeitink, Jan A. M. [1 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Nijmegen Ctr Mitochondrial Disorders, Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Lab Med, Nijmegen, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Dept Radiol & Nucl Med, Nijmegen, Netherlands
[4] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands
[5] Radboud Univ Nijmegen Med Ctr, Dept Gen Internal Med, Nijmegen, Netherlands
关键词
GROWTH-FACTOR; 21; MITOCHONDRIAL DISEASE; INSULIN-RESISTANCE; ANOREXIA-NERVOSA; MELAS SYNDROME; MUTATION; BIOMARKER; MUSCLE; BLOOD; HETEROPLASMY;
D O I
10.1212/WNL.0000000000000578
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To determine the value of fibroblast growth factor 21 (FGF21), a recently discovered biomarker for mitochondrial disease, in predicting clinical disease severity and disease progression in adult carriers of the m. 3243A>G mutation. Methods: In the context of a national inventory, the heteroplasmy levels of the m. 3243A>G mutation were measured in leukocytes and urinary epithelial cells. The Newcastle Mitochondrial Disease Adult Scale score was determined and blood was drawn for measuring FGF21 concentration. Twenty-five of the included initial patients studied were then selected randomly for a follow-up study. Results: This prognostic study included 99 adult carriers of the m. 3243A>G mutation. Our analysis revealed a moderate, significant correlation between FGF21 concentration and disease severity (r = 0.49; p = <0.001). No significant correlations were found between disease severity and the heteroplasmy percentage determined in urinary epithelial cells or the heteroplasmy percentage determined in leukocytes. Weak but significant correlations were also found between FGF21 concentration and the severity of the myopathy (r = 0.38; p <0.001) and between the concentration of FGF21 and the severity of the encephalopathy (r = 0.30; p <0.001). Repeated measurements following 25 subjects for 2 years revealed no significant correlation between FGF21 concentration and disease progression. Conclusions: Measuring FGF21 concentration had little added value in monitoring and predicting the disease course in this specific patient group.
引用
收藏
页码:125 / 133
页数:9
相关论文
共 24 条
  • [1] Elevated FGF21 secretion, PGC-1α and ketogenic enzyme expression are hallmarks of iron-sulfur cluster depletion in human skeletal muscle
    Crooks, Daniel R.
    Natarajan, Thanemozhi G.
    Jeong, Suh Young
    Chen, Chuming
    Park, Sun Young
    Huang, Hongzhan
    Ghosh, Manik C.
    Tong, Wing-Hang
    Haller, Ronald G.
    Wu, Cathy
    Rouault, Tracey A.
    [J]. HUMAN MOLECULAR GENETICS, 2014, 23 (01) : 24 - 39
  • [2] Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease
    Davis, Ryan L.
    Liang, Christina
    Edema-Hildebrand, Fabienne
    Riley, Catherine
    Needham, Merrilee
    Sue, Carolyn M.
    [J]. NEUROLOGY, 2013, 81 (21) : 1819 - 1826
  • [3] Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A &gt; G mutation
    de Laat, Paul
    Koene, Saskia
    van den Heuvel, Lambert P. W. J.
    Rodenburg, Richard J. T.
    Janssen, Mirian C. H.
    Smeitink, Jan A. M.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2012, 35 (06) : 1059 - 1069
  • [4] Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients
    Domingo, Pere
    Gallego-Escuredo, Jose M.
    Domingo, Joan C.
    del Mar Gutierrez, Maria
    Mateo, Maria G.
    Fernandez, Irene
    Vidal, Francesc
    Giralt, Marta
    Villarroya, Francesc
    [J]. AIDS, 2010, 24 (17) : 2629 - 2637
  • [5] Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa
    Dostalova, Ivana
    Kavalkova, Petra
    Haluzikova, Denisa
    Lacinova, Zdena
    Mraz, Milos
    Papezova, Hana
    Haluzik, Martin
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (09) : 3627 - 3632
  • [6] Fibroblast Growth Factor-21 May Mediate Growth Hormone Resistance in Anorexia Nervosa
    Fazeli, Pouneh K.
    Misra, Madhusmita
    Goldstein, Mark
    Miller, Karen K.
    Klibanski, Anne
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (01) : 369 - 374
  • [7] Fibroblast Growth Factor 21 Levels in Young Healthy Females Display Day and Night Variations and Are Increased in Response to Short-Term Energy Deprivation Through a Leptin-Independent Pathway
    Foo, Joo-Pin
    Aronis, Konstantinos N.
    Chamberland, John P.
    Paruthi, Jason
    Moon, Hyun-Seuk
    Mantzoros, Christos S.
    [J]. DIABETES CARE, 2013, 36 (04) : 935 - 942
  • [8] The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARα activation in man
    Gaelman, Cecilia
    Lundasen, Tomas
    Kharitonenkov, Alexei
    Bina, Holly A.
    Eriksson, Mats
    Hafstroem, Ingiaeld
    Dahlin, Maria
    Amark, Per
    Angelin, Bo
    Rudling, Mats
    [J]. CELL METABOLISM, 2008, 8 (02) : 169 - 174
  • [9] Fibroblast Growth Factor-21 Is Induced in Human Skeletal Muscles by Hyperinsulinemia
    Hojman, Pernille
    Pedersen, Maria
    Nielsen, Anders Rinnov
    Krogh-Madsen, Rikke
    Yfanti, Christina
    Akerstrom, Thorbjorn
    Nielsen, Soren
    Pedersen, Bente Klarlund
    [J]. DIABETES, 2009, 58 (12) : 2797 - 2801
  • [10] A detailed investigation of maternally inherited diabetes and deafness (MIDD) including clinical characteristics, C-peptide secretion, HLA-DR and -DQ status and autoantibody pattern
    Hosszufalusi, Nora
    Karcagi, Veronika
    Horvath, Rita
    Palik, Eva
    Varkonyi, Judit
    Rajczy, Katalin
    Prohaszka, Zoltan
    Szentirmai, Csaba
    Karadi, Istvan
    Romics, Laszlo
    Panczel, Pal
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2009, 25 (02) : 127 - 135